Dominant Negative ATM Mutations in Breast Cancer Families
about
Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumoursStudy design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE studyNo evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancerWorkshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002.The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancerFrequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer familiesCommon ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control studyMutation analysis of the ATR gene in breast and ovarian cancer families.Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.DNA-Repair Defects and Olaparib in Metastatic Prostate CancerPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSRadiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.ATM variants and cancer risk in breast cancer patients from Southern Finland.Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.Hemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis.FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer.Development of serous ovarian cancer is associated with the expression of homologous recombination pathway proteins.Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.Missense mutations in pyruvate kinase M2 promote cancer metabolism, oxidative endurance, anchorage independence, and tumor growth in a dominant negative manner.Cancer risks and mortality in heterozygous ATM mutation carriers.Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.ATM and breast cancer susceptibility.A PALB2 mutation associated with high risk of breast cancer.Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphomaVariation in the RAD51 gene and familial breast cancer.Risk assessment and management of high risk familial breast cancer.Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.ProphNet: a generic prioritization method through propagation of informationRare variants in the ATM gene and risk of breast cancerA Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls.The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice.INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells
P2860
Q24597674-A75ED747-8E0D-4D1F-AFAA-D38A2D6211C2Q24794680-A54F1032-D7C6-4C98-96B3-DB65781348E3Q24800108-B9ADA5FF-E9E9-47FC-92C5-A54F1237DE04Q24800356-BA54B039-FAF9-4E2D-B89E-76B7D71A591CQ24806109-D599FB3D-2B33-46A8-8771-E237B4B287DEQ24806235-3B17B6F2-E74B-4076-B343-95D3FF274FFBQ24806302-B6CBC6EC-0029-4914-B2C9-E0F6A0D8A0B0Q24810690-EC31419A-ABE5-4AEF-925B-3201F6BDB061Q24813163-68F4CD12-320D-4963-A9BB-37C546C881A2Q25257392-5FB5367F-3639-4863-9D15-E4895DFD7F29Q27853235-6FF390F9-6DE7-42E2-B607-22871333F619Q28584533-11727555-12BC-4092-995D-3015E496F4B8Q30432746-CD1F38BE-19E9-4B1D-A181-631A38940D0FQ30437897-782F039B-2077-4E6F-BFB0-021D54594F01Q30478981-0B65A101-A1BA-4E9F-A8D5-3D13E11FD50AQ33221678-9B54BF5C-C0BB-4FC8-8454-C73C3B45FEA2Q33254230-43416EDF-FDED-4362-AAF3-AA2FBA252739Q33258847-FD5A2033-7BF1-46D1-A2E7-17150644F6EBQ33708522-2BBC8352-2ED7-4C8A-8A82-396787685B80Q33711869-E9FB36D6-8398-4E0A-9A43-999DC49A6193Q34209800-5D66E684-2598-4635-9448-AE0ED769C3D4Q34253229-7F07880D-0B38-4F51-BE6B-7E109A546323Q34324063-1EB74175-1556-4670-949D-DC26B618A928Q34363589-0CF67216-8F6D-49AA-9805-01348335F7CFQ34401981-CD186A77-7AFC-4D2D-81D0-4335DCE7115FQ34422846-480BF323-C54A-4FF3-BAC1-EA3C57D1A9B8Q34480599-FD7C6017-1F56-4864-A6B6-A77E368D43DEQ34546389-CBB0F5A4-07CF-439B-BF3A-3D927B93ECE5Q34568565-54A402C7-8F42-453A-9770-7F9ECBE1DA61Q34613667-6DFEEFD6-E7EB-43B3-B399-3DFA9422BC5DQ34983013-914B1F26-9A99-4642-A83A-28EC02AE0686Q35012867-9ED4D2A1-44D8-4BF7-AD5D-7D9C40108969Q35019822-8555DC38-9B36-4C14-B3A2-3B53C28A5EA5Q35029565-50F5AA08-F89B-4716-9173-FE840FB63936Q35101468-92B31358-FACF-46A0-BF32-3EF0E9AB83F5Q35608690-6AD59962-BDBC-493C-A85B-80610DC57DCFQ35712499-951A79A5-4B84-4DCB-867A-4C1937AE4020Q35746371-FF8CC460-38B2-43AA-9510-31136D11BEDAQ35841140-D1FC3145-CC7F-4E6B-93C1-ACDF86338271Q35909521-02D683B6-F8FC-4F00-869C-D5870FBF236F
P2860
Dominant Negative ATM Mutations in Breast Cancer Families
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dominant Negative ATM Mutations in Breast Cancer Families
@ast
Dominant Negative ATM Mutations in Breast Cancer Families
@en
Dominant Negative ATM Mutations in Breast Cancer Families
@en-gb
type
label
Dominant Negative ATM Mutations in Breast Cancer Families
@ast
Dominant Negative ATM Mutations in Breast Cancer Families
@en
Dominant Negative ATM Mutations in Breast Cancer Families
@en-gb
prefLabel
Dominant Negative ATM Mutations in Breast Cancer Families
@ast
Dominant Negative ATM Mutations in Breast Cancer Families
@en
Dominant Negative ATM Mutations in Breast Cancer Families
@en-gb
P3181
P356
P1476
Dominant Negative ATM Mutations in Breast Cancer Families
@en
P304
P3181
P356
10.1093/JNCI/94.3.205
P407
P577
2002-02-06T00:00:00Z